• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Trends and Developments in HIV Research Neeta Ratanghayra
    March 30, 2022
    Novel treatment strategies and advances in care have transformed the lives of people living with HIV (human immunodeficiency virus). Antiretroviral therapy (ART), once-daily single-tablet regimens (STRs)...
  • Gilead's Truvada for PrEP can reduce HIV rates, but activists decry unequal access fiercepharma
    July 26, 2018
    Groups around the world are working hard to develop HIV vaccines, but in the meantime, Gilead Sciences reports that Truvada can significantly reduce the rate of new infections when used as a pre-exposure prophylaxis.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service